Joanna E. Fardell

Dr. Joanna E. Fardell


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2016 in Journal of Cancer Survivorship
Verified
Journal Article
Closed access
PDF file
JFJoanna E. Fardell
Joanna E. Fardell
BTBelinda Thewes
Belinda Thewes
JTJane Turner
Jane Turner
JGJemma Gilchrist
Jemma Gilchrist
LSLouise Sharpe
Louise Sharpe
PBPhyllis Butow
Phyllis Butow

23 May 2017 in Child: Care, Health and Development
Verified
Journal Article
Closed access
PDF file
ALA. Lum
A. Lum
CWClaire E Wakefield
Claire E Wakefield
BDB. Donnan
B. Donnan
MBM. A. Burns
M. A. Burns
JFJoanna E. Fardell
Joanna E. Fardell
GMG. M. Marshall
G. M. Marshall

28 July 2017 in Psycho-Oncology
Verified
Journal Article
Closed access
PDF file
JFJoanna E. Fardell
Joanna E. Fardell
GJGeorden Jones
Georden Jones
ASAllan Ben Smith
Allan Ben Smith
SLSophie Lebel
Sophie Lebel
BTBelinda Thewes
Belinda Thewes
PBPhyllis Butow
Phyllis Butow

6 September 2011 in Psychopharmacology
Verified
Journal Article
Closed access
PDF file
JFJoanna E. Fardell
Joanna E. Fardell
JVJanette Vardy
Janette Vardy
JSJeanette D. Shah
Jeanette D. Shah
IJIan N. Johnston
Ian N. Johnston

6 March 2017 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
JFJoanna E. Fardell
Joanna E. Fardell
JVJanine Vetsch
Janine Vetsch
TTToby Trahair
Toby Trahair
MMMarion Mateos
Marion Mateos
MGM. A. Grootenhuis
M. A. Grootenhuis
CWC. E. Wakefield
C. E. Wakefield

23 April 2013 in BMC Cancer
Verified
Journal Article
Open access
PDF file
MGmembers of the Conquer Fear Authorship Group
members of the Conquer Fear Authorship Group
PBPhyllis N Butow
Phyllis N Butow
MBMelanie L Bell
Melanie L Bell
ASAllan Ben Smith
Allan Ben Smith
JFJoanna E. Fardell
Joanna E. Fardell
CMCathrine Mihalopoulos
Cathrine Mihalopoulos
Up to 70% of cancer survivors report clinically significant levels of fear of cancer recurrence (FCR). Despite the known negative impact of FCR on psychological wellbeing and quality of life, little research has investigated interventions for high FCR. Our team has developed and piloted a novel intervention (Conquer Fear) based on the Self-Regulatory Executive Function Model and Relational Frame Theory and is evaluating Conquer Fear in a randomised controlled trial (RCT). We aim to compare the efficacy and cost-efficacy of the Conquer Fear Intervention and relaxation training in reducing the impact of FCR. This study is a multi-centre RCT with 260 participants randomised either to the Conquer Fear Intervention or relaxation training. Both interventions will be delivered in five sessions over 10 weeks by trained psychologists, psychiatrists and social workers with five or more years experience in oncology. Conquer Fear sessions use attentional training, detached mindfulness, meta-cognitive therapy, values clarification and psycho-education to help patients change the way they regulate and respond to thoughts about cancer recurrence. Relaxation training includes training in progressive and passive muscle relaxation, meditative relaxation, visualisation and “quick relaxation” techniques. Relaxation was chosen to control for therapist time and attention and has good face-validity as an intervention. The primary outcome is fear of cancer recurrence. Secondary outcomes include distress, quality of life, unmet needs, and health care utilisation. Participants complete questionnaires prior to starting the intervention, immediately after completing the intervention, 3 and 6 months later. Eligible participants are early-stage breast or colorectal cancer survivors who have completed hospital-based treatment between 2 months and 5 years prior to study entry and report a score in the clinical range on the Fear of Cancer Recurrence Inventory. The biostatistician is blinded to group allocation and participants are blinded to which intervention is being evaluated. Randomisation is computer generated, stratified by therapist, and uses sequentially numbered sealed envelopes. If successful, the study will provide an evidence-based intervention to reduce psychological morbidity in cancer survivors, and reduce overall health care costs due to more appropriate use of follow-up care and other health services in this very large population. Trial registration: ACTRN12612000404820